37501395	O	O
FULL	O	O
RESULT	O	O
:	O	O
Examination	O	O
:	O	O
Chest	O	O
CT	O	O
with	O	O
contrast	O	O
,	O	O
06/05/2008	O	O
Clinical	O	O
History	O	O
:	O	O
Breast	O	O
cancer	O	O
,	O	O
follow	O	O
up	O	O
pulmonary	O	O
nodules	O	O
.	O	O
Comparison	O	O
:	O	O
12/17/2007	O	O
.	O	O
Findings	O	O
:	O	O
Spiral	O	O
CT	O	O
of	O	O
the	O	O
chest	O	O
was	O	O
performed	O	O
with	O	O
2.5-mm	O	O
collimation	O	O
using	O	O
intravenous	O	O
contrast	O	O
.	O	O
The	O	O
cardiac	O	O
chamber	O	O
sizes	O	O
are	O	O
normal	O	O
.	O	O
Coronary	3_Yellow_Days	O
artery	3_Yellow_Days	O
calcifications	3_Yellow_Days	O
are	O	O
present	O	O
.	O	O
Tiny	3_Yellow_Days	O
pericardial	3_Yellow_Days	O
effusion	3_Yellow_Days	O
.	O	O
Adenopathy	3_Yellow_Days	O
at	3_Yellow_Days	O
the	3_Yellow_Days	O
right	3_Yellow_Days	O
hilum	3_Yellow_Days	O
and	3_Yellow_Days	O
ill-defined	3_Yellow_Days	O
right	3_Yellow_Days	O
and	3_Yellow_Days	O
left	3_Yellow_Days	O
paratracheal	3_Yellow_Days	O
lymph	3_Yellow_Days	O
nodes	3_Yellow_Days	O
are	3_Yellow_Days	O
unchanged	3_Yellow_Days	O
.	O	O
There	O	O
are	O	O
a	O	O
number	O	O
of	O	O
scattered	3_Yellow_Days	O
small	3_Yellow_Days	3_Yellow_Days
pulmonary	3_Yellow_Days	3_Yellow_Days
nodules	3_Yellow_Days	3_Yellow_Days
in	O	O
the	O	O
1-3-mm	O	O
range	O	O
of	O	O
size	O	O
in	O	O
both	3_Yellow_Days	O
lungs	3_Yellow_Days	O
.	O	O
There	O	O
is	O	O
a	O	O
little	O	O
lesser	O	O
degree	O	O
of	O	O
inspiration	O	O
with	O	O
increased	O	O
attenuation	O	O
of	O	O
lung	O	O
bases	O	O
with	O	O
some	O	O
minimal	O	O
dependent	O	O
atelectasis	O	O
.	O	O
No	O	O
effusion	O	O
.	O	O
Low	O	O
attenuation	O	O
hepatic	O	O
lesions	O	O
are	O	O
presumably	O	O
simple	O	O
cysts	O	O
.	O	O
Cholecystectomy	O	O
clips	O	O
and	O	O
nephrectomy	O	O
clips	O	O
on	O	O
the	O	O
right	O	O
.	O	O
The	O	O
remainder	O	O
of	O	O
the	O	O
visualized	O	O
upper	O	O
abdomen	O	O
is	O	O
unremarkable	O	O
.	O	O
IMPRESSION	O	O
:	O	O
Adenopathy	3_Yellow_Days	O
and	3_Yellow_Days	O
tiny	3_Yellow_Days	3_Yellow_Days
pulmonary	3_Yellow_Days	3_Yellow_Days
nodules	3_Yellow_Days	3_Yellow_Days
remain	3_Yellow_Days	3_Yellow_Days
unchanged	3_Yellow_Days	3_Yellow_Days
and	3_Yellow_Days	O
nonspecific	3_Yellow_Days	O
over	3_Yellow_Days	O
almost	3_Yellow_Days	O
a	3_Yellow_Days	O
year	3_Yellow_Days	O
now	3_Yellow_Days	O
.	O	O
Active	3_Yellow_Days	O
metastatic	3_Yellow_Days	O
disease	3_Yellow_Days	O
is	3_Yellow_Days	O
unlikely	3_Yellow_Days	O
.	O	O
They	3_Yellow_Days	O
may	3_Yellow_Days	O
be	3_Yellow_Days	O
followed	3_Yellow_Days	O
up	3_Yellow_Days	3_Yellow_Days
to	3_Yellow_Days	3_Yellow_Days
document	3_Yellow_Days	3_Yellow_Days
long	3_Yellow_Days	3_Yellow_Days
term	3_Yellow_Days	3_Yellow_Days
stability	3_Yellow_Days	3_Yellow_Days
.	O	O
CT	O	O
CT	O	O
,	O	O
LUNG	O	O
,	O	O
MED	O	O
,	O	O
PLEURA	O	O
W/CONTRAST	O	O
MCW	O	O
1821665	O	O
AMS	O	O
CT	O	O
THORAX	O	O
&	O	O
CT	O	O
PELVIS	O	O
-LRB-	O	O
745B-C	O	O
-RRB-	O	O
:	O	O
TECHNIQUE	O	O
:	O	O
HELICAL	O	O
CT	O	O
OF	O	O
THE	O	O
CHEST	O	O
WAS	O	O
PERFORMED	O	O
FOLLOWING	O	O
ADMINISTRATION	O	O
OF	O	O
120	O	O
CC	O	O
OF	O	O
OMNIPAQUE-350	O	O
.	O	O
1.25	O	O
MM	O	O
AXIAL	O	O
IMAGES	O	O
AND	O	O
2.5	O	O
MM	O	O
CORONAL	O	O
AND	O	O
SAGITTAL	O	O
IMAGES	O	O
WERE	O	O
REVIEWED	O	O
.	O	O
DELAYED	O	O
NONCONTIGUOUS	O	O
IMAGES	O	O
THROUGH	O	O
THE	O	O
UPPER	O	O
PORTION	O	O
OF	O	O
THE	O	O
LOWER	O	O
EXTREMITIES	O	O
WERE	O	O
LATER	O	O
ACQUIRED	O	O
.	O	O
COMPARISON	O	O
STUDY	O	O
CT	O	O
CHEST	O	O
WITH	O	O
CONTRAST	O	O
DATED	O	O
-LSB-	O	O
date	O	O
-RSB-	O	O
.	O	O
THE	O	O
OPACIFICATION	O	O
OF	O	O
THE	O	O
PULMONARY	O	O
VESSELS	O	O
IS	O	O
ADEQUATE	O	O
.	O	O
THERE	O	O
IS	O	O
NO	O	O
EVIDENCE	O	O
OF	O	O
ACUTE	O	O
OR	O	O
CHRONIC	O	O
PULMONARY	O	O
EMBOLISM	O	O
.	O	O
THERE	O	O
IS	O	O
UNCHANGED	O	O
INCREASED	O	O
CALIBER	O	O
OF	O	O
THE	O	O
CENTRAL	O	O
PULMONARY	O	O
ARTERIES	O	O
INDICATING	O	O
PULMONARY	3_Yellow_Days	3_Yellow_Days
HYPERTENSION	3_Yellow_Days	3_Yellow_Days
.	O	O
THERE	O	O
IS	O	O
DIFFUSE	1_Red_Minutes	3_Yellow_Days
MARKED	1_Red_Minutes	3_Yellow_Days
CARDIOMEGALY	1_Red_Minutes	3_Yellow_Days
WITH	O	O
HYPERTROPHY	O	3_Yellow_Days
OF	O	O
THE	O	O
LEFT	O	O
VENTRICLE	O	O
AND	O	O
MARKED	O	O
ENLARGEMENT	O	O
OF	O	O
THE	O	O
RIGHT	O	O
ATRIUM	O	O
.	O	O
THE	O	O
INTERVENTRICULAR	O	O
SEPTUM	O	O
IS	O	O
NOT	O	O
DEVIATED	O	O
.	O	O
THERE	O	O
IS	O	O
A	O	O
PERSISTENT	O	3_Yellow_Days
SMALL	3_Yellow_Days	3_Yellow_Days
PERICARDIAL	3_Yellow_Days	3_Yellow_Days
EFFUSION	3_Yellow_Days	3_Yellow_Days
.	O	O
THERE	O	O
IS	O	O
EDEMA	3_Yellow_Days	O
THROUGHOUT	3_Yellow_Days	O
THE	3_Yellow_Days	O
MEDIASTINUM	3_Yellow_Days	O
.	O	O
THE	O	O
PREVIOUSLY	O	O
SEEN	O	O
ADENOPATHY	3_Yellow_Days	O
IN	3_Yellow_Days	O
BOTH	3_Yellow_Days	O
PULMONARY	3_Yellow_Days	O
HILA	3_Yellow_Days	O
IS	3_Yellow_Days	O
STABLE	3_Yellow_Days	3_Yellow_Days
.	O	O
THE	O	O
LARGEST	O	O
NODES	O	O
IN	O	O
THE	O	O
RIGHT	O	O
HILUM	O	O
MEASURE	O	O
UP	O	O
TO	O	O
29	O	O
X	O	O
24	O	O
MM	O	O
AND	O	O
ON	O	O
THE	O	O
LEFT	O	O
SIDE	O	O
UP	O	O
TO	O	O
19	O	O
X	O	O
16	O	O
MM	O	O
.	O	O
THERE	O	O
IS	O	O
SIGNIFICANT	1_Red_Minutes	3_Yellow_Days
AMOUNT	1_Red_Minutes	3_Yellow_Days
OF	1_Red_Minutes	3_Yellow_Days
SECRETIONS	1_Red_Minutes	3_Yellow_Days
WITHIN	1_Red_Minutes	3_Yellow_Days
THE	1_Red_Minutes	3_Yellow_Days
LEFT	1_Red_Minutes	3_Yellow_Days
MAIN	1_Red_Minutes	3_Yellow_Days
STEM	1_Red_Minutes	3_Yellow_Days
BRONCHUS	1_Red_Minutes	3_Yellow_Days
.	O	O
AN	O	O
ENDOTRACHEAL	1_Red_Minutes	O
TUBE	1_Red_Minutes	O
IS	1_Red_Minutes	O
SEEN	1_Red_Minutes	O
IN	1_Red_Minutes	O
THE	1_Red_Minutes	O
PROXIMAL	1_Red_Minutes	O
RIGHT	1_Red_Minutes	O
MAIN	1_Red_Minutes	O
STEM	1_Red_Minutes	O
BRONCHUS	1_Red_Minutes	O
.	O	O
THE	O	O
NG	O	O
TUBE	O	O
IS	O	O
IN	O	O
PLACE	O	O
.	O	O
THE	O	O
ESOPHAGUS	O	O
IS	O	O
UNREMARKABLE	O	O
.	O	O
SEVERE	3_Yellow_Days	O
______	3_Yellow_Days	O
PANLOBULAR	3_Yellow_Days	O
EMPHYSEMA	3_Yellow_Days	O
IS	O	O
NOTED	O	O
THROUGHOUT	O	O
BOTH	O	O
LUNGS	O	O
.	O	O
THERE	O	O
ARE	O	O
ALSO	O	O
PERSISTENT	3_Yellow_Days	O
DIFFUSE	3_Yellow_Days	O
AREAS	3_Yellow_Days	O
OF	3_Yellow_Days	O
MOSAIC	3_Yellow_Days	O
PERFUSION	3_Yellow_Days	O
,	3_Yellow_Days	O
STABLE	3_Yellow_Days	O
IN	O	O
APPEARANCE	O	O
.	O	O
DUE	O	O
TO	O	O
THEIR	O	O
STABILITY	O	O
OVERTIME	O	O
THESE	O	O
ARE	O	O
THOUGHT	O	O
TO	O	O
REPRESENT	O	3_Yellow_Days
CHANGES	O	3_Yellow_Days
SECONDARY	O	3_Yellow_Days
TO	O	O
SMALL	O	O
AIRWAYS	O	O
DISEASE	O	O
.	O	O
MILD	3_Yellow_Days	O
BRONCHIECTASIS	3_Yellow_Days	O
IS	O	O
ALSO	O	O
SEEN	O	O
THROUGHOUT	O	O
BOTH	3_Yellow_Days	O
LUNGS	3_Yellow_Days	O
.	O	O
SOME	3_Yellow_Days	O
OF	O	O
THE	O	O
PERIPHERAL	O	O
BRONCHI	O	O
APPEAR	O	O
THICK	O	O
,	O	O
LIKELY	O	O
RELATED	O	O
TO	O	O
PERIBRONCHIAL	3_Yellow_Days	3_Yellow_Days
EDEMA	3_Yellow_Days	3_Yellow_Days
.	O	O
THERE	O	O
IS	O	O
A	O	O
PERSISTENT	O	O
NODULAR	O	O
SCAR	O	O
IN	O	O
THE	O	O
MEDIAL	O	O
ASPECT	O	O
OF	O	O
THE	O	O
LEFT	O	O
LUNG	O	O
WITH	O	O
A	O	O
CENTRAL	O	O
CALCIFICATION	O	O
.	O	O
THERE	O	O
IS	O	O
A	O	O
NEW	1_Red_Minutes	O
NODULAR	1_Red_Minutes	O
DENSITY	1_Red_Minutes	O
IN	O	O
THE	O	O
POSTERIOR	O	O
ASPECT	O	O
OF	O	O
THE	O	O
RIGHT	1_Red_Minutes	O
UPPER	1_Red_Minutes	O
LOBE	1_Red_Minutes	O
-LRB-	O	O
IMAGE	O	O
#	O	O
72	O	O
-RRB-	O	O
,	O	O
MEASURING	O	O
ABOUT	O	O
8	O	O
X	O	O
6	O	O
MM	O	O
IN	O	O
DIAMETER	O	O
.	O	O
SEVERAL	O	3_Yellow_Days
OTHER	O	3_Yellow_Days
NODULAR	O	3_Yellow_Days
SCARS	O	3_Yellow_Days
ARE	O	O
SEEN	O	O
IN	O	O
THE	O	O
RIGHT	O	O
LOWER	O	O
LOBE	O	O
-LRB-	O	O
IMAGE	O	O
#	O	O
181	O	O
-RRB-	O	O
,	O	O
AND	O	O
IN	O	O
THE	O	O
SUPERIOR	O	O
SEGMENT	O	O
FOR	O	O
THE	O	O
LEFT	O	O
LOWER	O	O
LOBE	O	O
-LRB-	O	O
IMAGE	O	O
#	O	O
77	O	O
-RRB-	O	O
.	O	O
SEVERAL	O	O
OTHER	O	3_Yellow_Days
TINY	O	3_Yellow_Days
SUBCENTIMETER	O	3_Yellow_Days
NODULES	O	3_Yellow_Days
APPEAR	O	3_Yellow_Days
TO	O	3_Yellow_Days
BE	O	3_Yellow_Days
STABLE	O	3_Yellow_Days
IN	O	O
SIZE	O	O
AND	O	O
NUMBER	O	O
.	O	O
THERE	O	O
ARE	O	O
NO	O	O
PLEURAL	O	O
EFFUSIONS	O	O
.	O	O
THERE	O	O
IS	O	O
DIFFUSE	1_Red_Minutes	O
ASCITES	1_Red_Minutes	O
AS	1_Red_Minutes	O
A	1_Red_Minutes	O
NEW	1_Red_Minutes	O
FINDING	1_Red_Minutes	O
.	O	O
THE	O	O
LIVER	3_Yellow_Days	O
IS	3_Yellow_Days	O
HETEROGENEOUS	3_Yellow_Days	O
,	O	O
ALTHOUGH	O	O
THE	O	O
SIGNIFICANCE	O	O
OF	O	O
THIS	O	O
FINDING	O	O
IS	O	O
UNCERTAIN	O	O
IN	O	O
THIS	O	O
SINGLE	O	O
PHASE	O	O
STUDY	O	O
.	O	O
THE	O	O
UTERUS	O	O
APPEARS	O	O
FIBROMATOUS	O	O
,	O	O
ALTHOUGH	O	O
UNCHANGED	O	O
.	O	O
THERE	O	O
IS	O	O
A	O	O
SIGNIFICANT	1_Red_Minutes	O
AMOUNT	1_Red_Minutes	O
OF	1_Red_Minutes	O
FLUID	1_Red_Minutes	O
IN	1_Red_Minutes	O
THE	1_Red_Minutes	O
PELVIS	1_Red_Minutes	O
.	O	O
A	O	O
BLADDER	O	O
CATHETER	O	O
IS	O	O
SEEN	O	O
IN	O	O
PLACE	O	O
.	O	O
THERE	O	O
ARE	O	O
NO	O	O
SIGNS	O	O
OF	O	O
ACUTE	O	O
OR	O	O
CHRONIC	O	O
DVT	O	O
.	O	O
THERE	O	O
IS	O	O
DIFFUSE	3_Yellow_Days	3_Yellow_Days
EDEMA	3_Yellow_Days	3_Yellow_Days
OF	3_Yellow_Days	3_Yellow_Days
THE	3_Yellow_Days	3_Yellow_Days
LOWER	3_Yellow_Days	O
EXTREMITIES	3_Yellow_Days	O
.	O	O
THERE	O	O
ARE	O	O
NO	O	O
FOCAL	O	O
BONY	O	O
LESIONS	O	O
.	O	O
1	O	O
.	O	O
NO	O	O
EVIDENCE	O	O
OF	O	O
ACUTE	O	O
OR	O	O
CHRONIC	O	3_Yellow_Days
PE	O	3_Yellow_Days
OR	O	3_Yellow_Days
DVT	O	3_Yellow_Days
.	O	O
2	O	O
.	O	O
UNCHANGED	O	3_Yellow_Days
DIFFUSE	1_Red_Minutes	3_Yellow_Days
CARDIOMEGALY	1_Red_Minutes	3_Yellow_Days
.	O	O
SIGNS	3_Yellow_Days	O
OF	3_Yellow_Days	O
PULMONARY	3_Yellow_Days	3_Yellow_Days
HYPERTENSION	3_Yellow_Days	3_Yellow_Days
.	O	O
3	O	O
.	O	O
STABLE	3_Yellow_Days	3_Yellow_Days
BILATERAL	3_Yellow_Days	3_Yellow_Days
HILAR	3_Yellow_Days	3_Yellow_Days
ADENOPATHY	3_Yellow_Days	3_Yellow_Days
.	O	O
THE	O	O
POSSIBILITY	3_Yellow_Days	O
OF	3_Yellow_Days	O
SARCOID	3_Yellow_Days	O
IS	O	O
RAISED	O	O
.	O	O
UNCHANGED	3_Yellow_Days	O
COPD	3_Yellow_Days	O
FINDINGS	3_Yellow_Days	O
.	O	O
4	O	O
.	O	O
NO	O	O
CHANGE	O	O
IN	O	O
THE	O	O
MOSAIC	O	O
PERFUSION	O	O
PATTERN	O	O
PROBABLY	O	O
DUE	O	O
TO	O	O
SMALL	3_Yellow_Days	3_Yellow_Days
AIRWAYS	3_Yellow_Days	3_Yellow_Days
DISEASE	3_Yellow_Days	3_Yellow_Days
.	O	O
5	O	O
.	O	O
BILATERAL	3_Yellow_Days	3_Yellow_Days
SMALL	3_Yellow_Days	3_Yellow_Days
PULMONARY	3_Yellow_Days	3_Yellow_Days
NODULES	3_Yellow_Days	3_Yellow_Days
AND	3_Yellow_Days	O
NODULAR	3_Yellow_Days	O
SCARS	3_Yellow_Days	O
.	O	O
AT	O	O
LEAST	O	O
THE	O	O
NODULAR	1_Red_Minutes	O
SCAR	1_Red_Minutes	O
DESCRIBING	1_Red_Minutes	O
THE	1_Red_Minutes	O
RIGHT	1_Red_Minutes	O
UPPER	1_Red_Minutes	O
LOBE	1_Red_Minutes	O
IS	1_Red_Minutes	O
NEW	1_Red_Minutes	O
.	O	O
A	O	O
FOLLOW-UP	1_Red_Minutes	O
IN	1_Red_Minutes	O
THREE	1_Red_Minutes	O
TO	1_Red_Minutes	O
SIX	1_Red_Minutes	3_Yellow_Days
MONTHS	1_Red_Minutes	3_Yellow_Days
IS	1_Red_Minutes	3_Yellow_Days
RECOMMENDED	1_Red_Minutes	3_Yellow_Days
.	O	O
6	O	O
.	O	O
ET	1_Red_Minutes	O
TUBE	1_Red_Minutes	O
IN	1_Red_Minutes	O
THE	1_Red_Minutes	O
RIGHT	1_Red_Minutes	O
MAIN	1_Red_Minutes	O
STEM	1_Red_Minutes	O
BRONCHUS	1_Red_Minutes	O
.	O	O
7	O	O
.	O	O
NG	O	O
TUBE	O	O
IN	O	O
PLACE	O	O
.	O	O
8	O	O
.	O	O
NEW	1_Red_Minutes	3_Yellow_Days
ASCITES	1_Red_Minutes	3_Yellow_Days
.	O	O
9	O	O
.	O	O
GENERALIZED	3_Yellow_Days	O
SUBCUTANEOUS	3_Yellow_Days	O
EDEMA	3_Yellow_Days	O
.	O	O
THE	O	O
FINDINGS	O	O
WERE	O	O
DISCUSSED	O	O
WITH	O	O
THE	O	O
PHYSICIAN	O	O
IN	O	O
CHARGE	O	O
AT	O	O
6:00	O	O
PM	O	O
ON	O	O
05/03	O	O
.	O	O
+	O	O
EXAMINATION	O	O
REVIEWED	O	O
&	O	O
REPORTED	O	O
FINDINGS	O	O
CONFIRMED	O	O
BY	O	O
:	O	O
-LSB-	O	O
doctor	O	O
-RSB-	O	O
.	O	O
37695890	O	O
FULL	O	O
RESULT	O	O
:	O	O
Examination	O	O
:	O	O
CT	O	O
Chest	O	O
,	O	O
07/21/2008	O	O
.	O	O
Clinical	O	O
History	O	O
:	O	O
Sarcoidosis	O	O
,	O	O
followup	O	O
.	O	O
Findings	O	O
:	O	O
CT	O	O
chest	O	O
7/12/2007	O	O
and	O	O
02/19/2008	O	O
.	O	O
Numerous	3_Yellow_Days	O
subcentimeter	3_Yellow_Days	O
nodules	3_Yellow_Days	O
,	3_Yellow_Days	O
in	3_Yellow_Days	O
parenchymal	3_Yellow_Days	O
or	3_Yellow_Days	O
subpleural	3_Yellow_Days	O
locations	3_Yellow_Days	O
,	3_Yellow_Days	O
and	3_Yellow_Days	O
spiculated	3_Yellow_Days	O
masses	3_Yellow_Days	O
,	3_Yellow_Days	O
like	3_Yellow_Days	O
a	3_Yellow_Days	O
band	3_Yellow_Days	O
of	3_Yellow_Days	O
fibrosis	3_Yellow_Days	O
,	3_Yellow_Days	O
are	3_Yellow_Days	O
noted	3_Yellow_Days	O
in	3_Yellow_Days	O
the	3_Yellow_Days	O
lungs	3_Yellow_Days	O
bilaterally	3_Yellow_Days	O
.	O	O
The	3_Yellow_Days	O
pre-existing	3_Yellow_Days	O
disease	3_Yellow_Days	O
has	3_Yellow_Days	O
been	3_Yellow_Days	O
relatively	3_Yellow_Days	3_Yellow_Days
stable	3_Yellow_Days	3_Yellow_Days
.	O	O
Additionally	O	O
,	O	O
there	O	O
is	O	O
a	O	O
localized	1_Red_Minutes	3_Yellow_Days
area	1_Red_Minutes	3_Yellow_Days
of	1_Red_Minutes	3_Yellow_Days
new	1_Red_Minutes	3_Yellow_Days
ground-glass	1_Red_Minutes	3_Yellow_Days
opacities	1_Red_Minutes	3_Yellow_Days
in	1_Red_Minutes	O
the	1_Red_Minutes	O
right	1_Red_Minutes	O
base	1_Red_Minutes	O
-LRB-	O	O
image	O	O
#	O	O
71	O	O
to	O	O
77	O	O
-RRB-	O	O
.	O	O
This	O	O
is	O	O
associated	O	O
with	O	O
peribronchial	O	3_Yellow_Days
thickening	O	3_Yellow_Days
and	O	O
nodules	O	O
.	O	O
This	1_Red_Minutes	O
could	1_Red_Minutes	O
represent	1_Red_Minutes	O
superimposed	1_Red_Minutes	O
infectious	1_Red_Minutes	O
process	1_Red_Minutes	O
.	O	O
However	O	O
,	O	O
the	O	O
progressing	1_Red_Minutes	O
sarcoidosis	1_Red_Minutes	O
is	1_Red_Minutes	O
probably	1_Red_Minutes	O
more	1_Red_Minutes	O
likely	1_Red_Minutes	3_Yellow_Days
.	O	O
Clinical	1_Red_Minutes	3_Yellow_Days
correlation	1_Red_Minutes	3_Yellow_Days
is	1_Red_Minutes	3_Yellow_Days
recommended	1_Red_Minutes	3_Yellow_Days
.	O	O
Additionally	O	O
,	O	O
there	O	O
are	O	O
multiple	3_Yellow_Days	3_Yellow_Days
enlarged	3_Yellow_Days	3_Yellow_Days
lymph	3_Yellow_Days	3_Yellow_Days
nodes	3_Yellow_Days	3_Yellow_Days
in	3_Yellow_Days	O
the	3_Yellow_Days	O
mediastinum	3_Yellow_Days	O
predominantly	O	O
at	O	O
the	O	O
prevascular	O	O
chain	O	O
,	O	O
right	O	O
paratracheal	O	O
chain	O	O
and	O	O
subcarinal	O	3_Yellow_Days
chains	O	3_Yellow_Days
as	O	O
well	O	O
as	O	O
in	O	O
the	O	O
hila	O	O
bilaterally	O	O
,	O	O
grossly	3_Yellow_Days	O
unchanged	3_Yellow_Days	O
.	O	O
There	O	O
is	O	O
no	O	O
evidence	O	O
of	O	O
new	O	O
lymph	O	O
node	O	O
or	O	O
lymphadenopathy	O	O
.	O	O
The	O	O
visualized	O	O
soft	O	O
tissue	O	O
is	O	O
unremarkable	O	O
.	O	O
IMPRESSION	O	O
:	O	O
Development	3_Yellow_Days	O
of	3_Yellow_Days	O
localized	3_Yellow_Days	O
area	3_Yellow_Days	O
of	3_Yellow_Days	O
ground-glass	3_Yellow_Days	O
opacities	3_Yellow_Days	O
in	3_Yellow_Days	O
the	3_Yellow_Days	O
right	3_Yellow_Days	3_Yellow_Days
lower	3_Yellow_Days	3_Yellow_Days
lobe	3_Yellow_Days	3_Yellow_Days
and	O	O
relatively	O	O
stable	O	O
disease	O	O
in	O	O
the	O	O
rest	O	O
of	O	O
the	O	O
lungs	O	O
,	O	O
mediastinum	O	O
,	O	O
and	O	O
hila	O	O
.	O	O
CT	O	O
CT	O	O
,	O	O
LUNG	O	O
,	O	O
MED	O	O
,	O	O
PLEURA	O	O
W/CONTRAST	O	O
302497186	O	O
22320	O	O
IMGCTT	O	O
CT	O	O
THORAX	O	O
CT	O	O
OF	O	O
THE	O	O
CHEST	O	O
:	O	O
05/22/2002	O	O
.	O	O
COMPARISON	O	O
:	O	O
Outside	O	O
CT	O	O
's	O	O
from	O	O
the	O	O
Hospital	O	O
of	O	O
the	O	O
University	O	O
of	O	O
Pennsylvania	O	O
,	O	O
dated	O	O
04/03/2002	O	O
and	O	O
02/12/2002	O	O
,	O	O
labelled	O	O
with	O	O
the	O	O
patient	O	O
's	O	O
name	O	O
.	O	O
Additional	O	O
comparison	O	O
is	O	O
made	O	O
to	O	O
a	O	O
CT	O	O
of	O	O
the	O	O
chest	O	O
from	O	O
this	O	O
institution	O	O
,	O	O
dated	O	O
01/07/2002	O	O
.	O	O
TECHNIQUE	O	O
:	O	O
Spiral	O	O
CT	O	O
acquisition	O	O
through	O	O
the	O	O
chest	O	O
,	O	O
without	O	O
intravenous	O	O
contrast	O	O
at	O	O
2	O	O
mm	O	O
slice	O	O
thickness	O	O
.	O	O
FINDINGS	O	O
:	O	O
The	O	O
comparisons	O	O
to	O	O
the	O	O
examinations	O	O
from	O	O
the	O	O
Hospital	O	O
of	O	O
the	O	O
University	O	O
of	O	O
Pennsylvania	O	O
are	O	O
of	O	O
limited	O	O
value	O	O
,	O	O
as	O	O
no	O	O
lung	O	O
windows	O	O
are	O	O
included	O	O
.	O	O
I	O	O
am	O	O
able	O	O
to	O	O
compare	O	O
from	O	O
the	O	O
lung	O	O
windows	O	O
from	O	O
the	O	O
study	O	O
at	O	O
this	O	O
institution	O	O
from	O	O
01/07/2002	O	O
.	O	O
There	O	O
as	O	O
been	3_Yellow_Days	O
marked	3_Yellow_Days	3_Yellow_Days
interval	3_Yellow_Days	3_Yellow_Days
improvement	3_Yellow_Days	3_Yellow_Days
in	3_Yellow_Days	3_Yellow_Days
the	3_Yellow_Days	3_Yellow_Days
bilateral	3_Yellow_Days	3_Yellow_Days
pulmonary	3_Yellow_Days	3_Yellow_Days
nodules	3_Yellow_Days	3_Yellow_Days
since	O	O
the	O	O
01/07/2002	O	O
examination	O	O
.	O	O
The	O	O
only	3_Yellow_Days	3_Yellow_Days
nodule	3_Yellow_Days	3_Yellow_Days
remaining	3_Yellow_Days	3_Yellow_Days
is	O	O
a	O	O
3	O	3_Yellow_Days
mm	O	3_Yellow_Days
nodule	O	3_Yellow_Days
in	O	O
the	O	O
right	3_Yellow_Days	O
upper	3_Yellow_Days	O
lobe	3_Yellow_Days	O
on	O	O
image	O	O
no.	O	O
60	O	O
of	O	O
series	O	O
3	O	O
,	O	O
which	O	O
is	O	O
stable	O	O
since	O	O
01/07/2002	O	O
.	O	O
No	O	O
pleural	O	O
or	O	O
pericardial	O	O
effusions	O	O
.	O	O
No	O	O
enlarged	O	O
axillary	O	O
,	O	O
hilar	O	O
or	O	O
mediastinal	O	O
lymph	O	O
nodes	O	O
are	O	O
identified	O	O
.	O	O
The	O	O
visualized	O	O
upper	O	O
abdominal	O	O
viscera	O	O
have	O	O
a	O	O
unremarkable	O	O
non-contrast	O	O
appearance	O	O
.	O	O
Review	O	O
of	O	O
skeletal	O	O
structures	O	O
does	O	O
not	O	O
reveal	O	O
any	O	O
suspicious	O	O
lytic	O	O
or	O	O
blastic	O	O
lesions	O	O
.	O	O
IMPRESSION	O	O
:	O	O
1	O	O
.	O	O
MARKED	3_Yellow_Days	3_Yellow_Days
INTERVAL	3_Yellow_Days	3_Yellow_Days
DECREASE	3_Yellow_Days	3_Yellow_Days
IN	3_Yellow_Days	3_Yellow_Days
BILATERAL	3_Yellow_Days	3_Yellow_Days
PULMONARY	3_Yellow_Days	3_Yellow_Days
NODULES	3_Yellow_Days	3_Yellow_Days
.	O	O
ONLY	3_Yellow_Days	O
A	3_Yellow_Days	O
3	3_Yellow_Days	O
MM	3_Yellow_Days	O
RIGHT	3_Yellow_Days	O
UPPER	3_Yellow_Days	O
LOBE	3_Yellow_Days	O
NODULE	3_Yellow_Days	O
REMAINS	3_Yellow_Days	O
SINCE	O	O
01/07/2002	O	O
,	O	O
AND	O	O
THIS	3_Yellow_Days	O
NODULE	3_Yellow_Days	O
IS	3_Yellow_Days	O
STABLE	3_Yellow_Days	O
SINCE	O	O
THAT	O	O
TIME	O	O
.	O	O
2	O	O
.	O	O
NO	O	O
EVIDENCE	O	O
OF	O	O
ENLARGED	O	O
LYMPH	O	O
NODES	O	O
IN	O	O
THE	O	O
CHEST	O	O
.	O	O
END	O	O
OF	O	O
IMPRESSION	O	O
:	O	O
SUMMARY	O	O
:	O	O
2	O	O
038.9	O	O
078.5	O	O
079.99	O	O
117.3	O	O
136.9	O	O
141.4	O	O
200.02	O	O
200.10	O	O
200.12	O	O
201.00	O	O

